Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Refractory Childhood Uveitis
NCT04150770Phase 4Unknown
- Start
- Jan 2017
- Primary completion
- Jan 2020
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of infliximab in uveitis. Status: unknown.
02
Drugs
infliximab
03
Conditions
uveitis
Beyond the preview
Go deeper on NCT04150770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04150770.